These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6014737)

  • 1. [Single dose studies on the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride on blood pressure and pulse in hypertonic subjects and on its tolerance].
    Knobloch H; Moor H
    Arzneimittelforschung; 1966 Sep; 16(9):1169-74. PubMed ID: 6014737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term testing of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride with special reference to the effect on blood pressure and carbohydrate metabolism].
    Krämer D; Krause W; Renner H
    Arzneimittelforschung; 1970 Apr; 20(4):519-21. PubMed ID: 5467817
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].
    Grabner G; Michalek P; Pokorny D; Vormittag E
    Arzneimittelforschung; 1966 Sep; 16(9):1174-9. PubMed ID: 6014738
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood pressure and heart rate of rats after repeated treatment with 2-(2,6-dichlorphenylamino)-2-imidazoline].
    Walland A
    Arzneimittelforschung; 1968 Jul; 18(7):833-6. PubMed ID: 5755830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood circulation studies with 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride].
    Kobinger W; Walland A
    Arzneimittelforschung; 1967 Mar; 17(3):292-300. PubMed ID: 5631221
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental study of kidney hemodynamics and the behavior of electrolytes after a single administration of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride].
    Baum P
    Arzneimittelforschung; 1966 Sep; 16(9):1162-5. PubMed ID: 6014735
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cerebral hemodynamics under the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride].
    Deisenhammer E; Klausberger EM
    Arzneimittelforschung; 1966 Sep; 16(9):1161-2. PubMed ID: 6014734
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of 2,6-dichlorphenylamino-imidazoline-HCl on blood pressure and plasma renin activity in rats].
    Rosenthal J; Hoefke W; Wolff HP
    Pflugers Arch; 1969; 312(1):R85-6. PubMed ID: 4311371
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride on the blood flow of the extremities, blood pressure and venous capacity in normotensive subjects].
    Ehringer H
    Arzneimittelforschung; 1966 Sep; 16(9):1165-9. PubMed ID: 6014736
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients.
    Hökfelt B; Hedeland H; Dymling JF
    Eur J Pharmacol; 1970; 10(3):389-97. PubMed ID: 5422465
    [No Abstract]   [Full Text] [Related]  

  • 11. On the problem of tolerance of 2-(2,6-dichlorophenylamino)-2-imidazoline.
    Walland A; Kobinger W
    Arzneimittelforschung; 1971 Jan; 21(1):61-5. PubMed ID: 5108202
    [No Abstract]   [Full Text] [Related]  

  • 12. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
    Koch G
    Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
    [No Abstract]   [Full Text] [Related]  

  • 13. On hypotensive action of some imidazoline derivatives of sulphonamidated aryloxyalkylcarboxylic acids.
    Soldea C; Oniscu C; Sunel V
    Rev Med Chir Soc Med Nat Iasi; 1992; 96(3-4):265-8. PubMed ID: 1344867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
    Borrello G
    Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of chronic administration of moxonidine in hypertensive rats SHR-SP].
    Khokhlova ON; Murashev AN; Lavrova LN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(5):21-3. PubMed ID: 11109519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of action of 2-(2,6-dichlorophenylamine)2-imidazoline hydrochloride. Experimental studies in normal animals].
    Brugger A; Oliver R; Salvá JA
    Rev Esp Fisiol; 1970 Mar; 26(1):1-8. PubMed ID: 5431809
    [No Abstract]   [Full Text] [Related]  

  • 17. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 18. [Catapresan (2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride)--a new intraocular pressure lowering agent].
    Hasslinger C
    Klin Monbl Augenheilkd; 1969 Jan; 154(1):95-105. PubMed ID: 5364293
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of manual versus ambulatory blood pressure measurements with pharmacokinetic-pharmacodynamic modeling of antihypertensive compounds: application to moxonidine.
    Trocóniz IF; de Alwis DP; Tillmann C; Callies S; Mitchell M; Schaefer HG
    Clin Pharmacol Ther; 2000 Jul; 68(1):18-27. PubMed ID: 10945312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of catapres, a new hypotensive drug: a preliminary report.
    Ng J; McGrgor DD; Taylor KM; Smirk H
    N Z Med J; 1967 Dec; 66(425):864-70. PubMed ID: 5236015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.